LAURIE KEATING - 29 Jul 2021 Form 3 Insider Report for Immuneering Corp (IMRX)

Role
Director
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Laurie B. Keating
Issuer symbol
IMRX
Transactions as of
29 Jul 2021
Transactions value $
$0
Form type
3
Filing time
29 Jul 2021, 20:53:41 UTC
Previous filing
14 Jul 2021
Next filing
04 Aug 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IMRX Stock Option 29 Jul 2021 Class A Common Stock 60,074 $4.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable as to 25% of the underlying shares on March 18, 2022 and then in equal monthly installments over the subsequent three years, subject to Ms. Keating's continued service on the Issuer's board of directors through each applicable vesting date.

Remarks:

Exhibit 24 - Power of Attorney